Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Alpha-lipoic acid (LA) has become a common ingredient in multivitamin formulas, anti-aging supplements, and even pet food. It is well-defined as a therapy for preventing diabetic polyneuropathies, and scavenges free radicals, chelates metals, and restores intracellular glutathione levels which otherwise decline with age. How do the biochemical properties of LA relate to its biological effects? Herein, we review the molecular mechanisms of LA discovered using cell and animal models, and the effects of LA on human subjects. Though LA has long been touted as an antioxidant, it has also been shown to improve glucose and ascorbate handling, increase eNOS activity, activate Phase II detoxification via the transcription factor Nrf2, and lower expression of MMP-9 and VCAM-1 through repression of NF-kappa B. LA and its reduced form, dihydrolipoic acid, may use their chemical properties as a redox couple to alter protein conformations by forming mixed disulfides. Beneficial effects are achieved with low micromolar levels of LA, suggesting that some of its therapeutic potential extends beyond the strict definition of an antioxidant. Current trials are investigating whether these beneficial properties of LA make it an appropriate treatment not just for diabetes, but also for the prevention of vascular disease, hypertension, and inflammation.

[1]  J. M. May,et al.  Uptake, recycling, and antioxidant actions of alpha-lipoic acid in endothelial cells. , 2002, Free radical biology & medicine.

[2]  L. Packer,et al.  The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. , 2007, Alternative medicine review : a journal of clinical therapeutic.

[3]  F. Cheema,et al.  Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study , 2005, Circulation.

[4]  B. Ames,et al.  Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Jacob,et al.  Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. , 1997, Life sciences.

[6]  E. Harrison,et al.  The metabolism of dl-(1,6-14C)lipoic acid in the rat. , 1974, Archives of biochemistry and biophysics.

[7]  B. Ames,et al.  (R)-α-Lipoic Acid Reverses the Age-Associated Increase in Susceptibility of Hepatocytes to tert-Butylhydroperoxide both In Vitro and In Vivo , 2000 .

[8]  U. Çakatay,et al.  Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle. , 2005, Archives of gerontology and geriatrics.

[9]  D. Leroith,et al.  A Molecular Basis for Insulin Resistance , 1997, The Journal of Biological Chemistry.

[10]  O. Lorenzo,et al.  Differential redox regulation within the PTP superfamily. , 2007, Cellular signalling.

[11]  K. Kraemer,et al.  Molecular aspects of lipoic acid in the prevention of diabetes complications. , 2001, Nutrition.

[12]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Hermann,et al.  Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers , 2003, Journal of clinical pharmacology.

[14]  D. Sanadi,et al.  alpha-Ketoglutaric dehydrogenase. 8. Isolation and some properties of a flavoprotein compnent. , 1960, The Journal of biological chemistry.

[15]  E. Chan,et al.  Distribution study of orally administered lipoic acid in rat brain tissues , 2009, Brain Research.

[16]  W. Müller,et al.  The potent free radical scavenger α-lipoic acid improves memory in aged mice: Putative relationship to NMDA receptor deficits , 1993, Pharmacology, Biochemistry and Behavior.

[17]  L. Packer,et al.  Antioxidant activities of dihydrolipoic acid and its structural homologues. , 1993, Free radical research communications.

[18]  S. Jacob,et al.  Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. , 1999, Free radical biology & medicine.

[19]  M. Shimizu,et al.  Transepithelial Transport of α-Lipoic Acid across Human Intestinal Caco-2 Cell Monolayers , 2007 .

[20]  Jiankang Liu,et al.  (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. , 2004, Archives of biochemistry and biophysics.

[21]  B. C. Scott,et al.  Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. , 1994, Free radical research.

[22]  V. Ravindranath,et al.  alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. , 1996, Brain research.

[23]  A. Bast,et al.  Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. , 1988, Biochimica et biophysica acta.

[24]  Takafumi Suzuki,et al.  Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity , 2008, Molecular and Cellular Biology.

[25]  R. Moreau,et al.  Is α‐lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity , 2008, IUBMB life.

[26]  H. Tritschler,et al.  α-Lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products , 1999 .

[27]  D. Cremer,et al.  Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. , 2006, Regulatory toxicology and pharmacology : RTP.

[28]  T. Meinertz,et al.  Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. , 2001, Free radical biology & medicine.

[29]  S. Jacob,et al.  The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. , 1996, Diabetes.

[30]  T. Hagen,et al.  Age-related decline of sodium-dependent ascorbic acid transport in isolated rat hepatocytes. , 2003, Archives of biochemistry and biophysics.

[31]  B. Ames,et al.  Age‐associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes—reversal with (R)‐α‐lipoic acid supplementation , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  D. Bourdette,et al.  Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis , 2006, Journal of Neuroimmunology.

[33]  H. Tritschler,et al.  Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? , 1995, Biochemical pharmacology.

[34]  D. Butterfield,et al.  The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice , 2003, Journal of neurochemistry.

[35]  Shenmin Zhang,et al.  A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells , 2008, Proceedings of the National Academy of Sciences.

[36]  R. Hermann,et al.  Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  L. Packer,et al.  R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. , 2002, Archives of biochemistry and biophysics.

[38]  L. Packer,et al.  α-Lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes , 2003 .

[39]  J. Park,et al.  α-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-κB transcriptional activity , 2007, Experimental & Molecular Medicine.

[40]  R. Somwar,et al.  The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. , 2001, Diabetes.

[41]  R. Fernandes,et al.  Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. , 2008, British journal of pharmacology.

[42]  A. Bush Metal complexing agents as therapies for Alzheimer’s disease , 2002, Neurobiology of Aging.

[43]  D. Hardie,et al.  5′-AMP-activated Protein Kinase Phosphorylates IRS-1 on Ser-789 in Mouse C2C12 Myotubes in Response to 5-Aminoimidazole-4-carboxamide Riboside* , 2001, The Journal of Biological Chemistry.

[44]  A. Bast,et al.  Scavenging of hypochlorous acid by lipoic acid. , 1991, Biochemical pharmacology.

[45]  Daniel C Liebler,et al.  Specific Patterns of Electrophile Adduction Trigger Keap1 Ubiquitination and Nrf2 Activation* , 2005, Journal of Biological Chemistry.

[46]  J. Keaney,et al.  Effect of Combined Treatment With α‐Lipoic Acid and Acetyl‐L‐Carnitine on Vascular Function and Blood Pressure in Patients With Coronary Artery Disease , 2007 .

[47]  D. Tomassoni,et al.  Pharmacokinetics of Different Formulations of Tioctic (Alpha-Lipoic) Acid in Healthy Volunteers , 2008, Clinical and experimental hypertension.

[48]  C. B. Pickett,et al.  Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-mediated Transcription* , 2002, The Journal of Biological Chemistry.

[49]  A Bast,et al.  The pharmacology of the antioxidant lipoic acid. , 1997, General pharmacology.

[50]  W. Woodward,et al.  Lipoic acid in multiple sclerosis: a pilot study , 2005, Multiple sclerosis.

[51]  B. Viollet,et al.  Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase , 2004, Nature Medicine.

[52]  C. Sen,et al.  Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[53]  H. Sies,et al.  Prevention of singlet oxygen-induced DNA damage by lipoate. , 1993, Chemico-biological interactions.

[54]  J. Wojtaszewski,et al.  Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[55]  H. Tritschler,et al.  Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. , 1999, Free radical research.

[56]  U. Çakatay,et al.  Effect of alpha‐lipoic acid supplementation on markers of protein oxidation in post‐mitotic tissues of ageing rat , 2006, Cell biochemistry and function.

[57]  C. Sen,et al.  Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization , 1997, BioFactors.

[58]  V. Ravindranath,et al.  α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats , 1996, Brain Research.

[59]  A. Kong,et al.  Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 , 2006, Molecular Cancer Therapeutics.

[60]  A. Klip,et al.  Stimulation of Glucose Uptake by the Natural Coenzyme α-Lipoic Acid/Thioctic Acid: Participation of Elements of the Insulin Signaling Pathway , 1996, Diabetes.

[61]  S. Vasdev,et al.  Salt-induced hypertension in WKY rats: Prevention by α-lipoic acid supplementation , 2003, Molecular and Cellular Biochemistry.

[62]  Su-Jane Wang,et al.  Presynaptic mechanisms underlying the α-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals , 2007, Neurochemistry International.

[63]  U. Henning Multienzyme complexes. , 1966, Angewandte Chemie.

[64]  Takahiro Shibata,et al.  Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1 , 2006, Molecular and Cellular Biology.

[65]  M. Hanefeld,et al.  Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). , 1995, Diabetologia.

[66]  P. Di Mascio,et al.  Singlet oxygen induced single-strand breaks in plasmid pBR322 DNA: the enhancing effect of thiols. , 1991, Biochimica et biophysica acta.

[67]  Wei-jian Zhang,et al.  α‐Lipoic acid inhibits TNF‐a‐induced NF‐κB activation and adhesion molecule expression in human aortic endothelial cells , 2001 .

[68]  N. Vaziri,et al.  Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. , 2005, American journal of physiology. Renal physiology.

[69]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[70]  A. Bast,et al.  Lipoic acid: A multifunctional antioxidant , 2003, BioFactors.

[71]  J. de Champlain,et al.  Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by &agr;-Lipoic Acid , 2002, Hypertension.

[72]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[73]  T. Foley,et al.  Oxidative Inhibition of Protein Phosphatase 2A Activity: Role of Catalytic Subunit Disulfides , 2007, Neurochemical Research.

[74]  F. Gries,et al.  Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) , 1997, Diabetes Care.

[75]  T. Silhavy,et al.  Lipoic Acid Metabolism in Escherichia coli : Isolation of Null Mutants Defective in Lipoic Acid Biosynthesis , Molecular Cloning and Characterization of the E . coli lip Locus , and Identification of the Lipoylated Protein of the Glycine Cleavage System , 2005 .

[76]  U. Munzel,et al.  Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.

[77]  Jun Ren,et al.  Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. , 2007, American journal of physiology. Cell physiology.

[78]  I. Leconte,et al.  Molecular basis of insulin resistance. , 1992, Hormone research.

[79]  S. Jacob,et al.  Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats , 1997 .

[80]  D. Cremer,et al.  Safety evaluation of α-lipoic acid (ALA) , 2006 .

[81]  H. Tritschler,et al.  Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[82]  M. Louhelainen,et al.  Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats , 2006, Journal of hypertension.

[83]  S. Jacob,et al.  Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. , 1995, Arzneimittel-Forschung.

[84]  B. Kornhuber,et al.  Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. , 1992, Arzneimittel-Forschung.

[85]  V. Ganapathy,et al.  Cloning and Functional Expression of a cDNA Encoding a Mammalian Sodium-dependent Vitamin Transporter Mediating the Uptake of Pantothenate, Biotin, and Lipoate* , 1998, The Journal of Biological Chemistry.

[86]  U. Ikeda,et al.  Interleukin‐6 and acute coronary syndrome , 2001, Clinical cardiology.

[87]  T. Hagen,et al.  Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[88]  John M Pezzuto,et al.  Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Morrow,et al.  Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)‐α‐lipoic acid , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[90]  P. Jones,et al.  Alpha-lipoic acid and cardiovascular disease. , 2003, The Journal of nutrition.

[91]  W. Zhang,et al.  Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[92]  B. Viollet,et al.  AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.

[93]  T. Hagen,et al.  Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A , 2009, Biogerontology.

[94]  E. Henriksen,et al.  Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats. , 2004, American journal of physiology. Endocrinology and metabolism.

[95]  R. Moreau,et al.  Mitochondrial Decay in the Aging Rat Heart , 2002 .

[96]  D. Tomassoni,et al.  Comparative Crossover, Randomized, Open-Label Bioequivalence Study on the Bioequivalence of Two Formulations of Thioctic Acid in Healthy Volunteers , 2007, Clinical and experimental hypertension.

[97]  J. Krieglstein,et al.  Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia , 1996, Neuropharmacology.

[98]  C. Cobelli,et al.  alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. , 1999, Diabetes care.

[99]  M. Mcgahan,et al.  Alpha lipoic acid changes iron uptake and storage in lens epithelial cells. , 2003, Experimental eye research.

[100]  P. O'Brien,et al.  The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid , 2003 .

[101]  Lingyun Wu,et al.  Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. , 2003, American journal of hypertension.

[102]  M. Takaoka,et al.  Effects of α-lipoic acid on deoxycorticosterone acetate–salt-induced hypertension in rats , 2001 .

[103]  S. Jacob,et al.  Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. , 1997, The American journal of physiology.

[104]  S. Vasdev,et al.  Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[105]  S. Vasdev,et al.  Dietary α‐lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats , 2000 .

[106]  L. Packer,et al.  Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. , 1996, Archives of biochemistry and biophysics.

[107]  Kyung-Ja Cho,et al.  Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice , 2006, Rheumatology International.

[108]  F. Gries,et al.  Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. , 1997, Diabetes care.

[109]  C. Sen,et al.  Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active α-lipoic acid , 1999, Cell Death and Differentiation.

[110]  A. Bast,et al.  A method for measuring nitric oxide radical scavenging activity. Scavenging properties of sulfur–containing compounds. , 1997, Pharmacy World and Science.

[111]  A. Bernkop‐Schnürch,et al.  Development of a Sustained Release Dosage Form for α‐Lipoic Acid. II. Evaluation in Human Volunteers , 2004, Drug development and industrial pharmacy.

[112]  D. Bourdette,et al.  Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck). , 2006, Biochemical and biophysical research communications.

[113]  T. Kronbach,et al.  New metabolic pathways of alpha-lipoic acid. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[114]  H. Tritschler,et al.  Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. , 1999, Clinical science.

[115]  L. Packer,et al.  Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. , 1998, Free radical biology & medicine.

[116]  J. Park,et al.  α-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma , 2004 .

[117]  L. Packer,et al.  alpha-Lipoic acid as a biological antioxidant. , 1995, Free radical biology & medicine.

[118]  Wei-jian Zhang,et al.  Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[119]  P. Varalakshmi,et al.  Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation. , 1999, Pharmacological research.

[120]  Wei-jian Zhang,et al.  α-Lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway , 2007, Proceedings of the National Academy of Sciences.

[121]  J. Trevithick,et al.  Modelling cortical cataractogenesis XX. In vitro effect of α‐lipoic acid on glutathione concentrations in lens in model diabetic cataractogenesis , 1998, Biochemistry and molecular biology international.

[122]  L. Roccatagliata,et al.  Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. , 2004, Journal of neuroimmunology.

[123]  M. Hanefeld,et al.  Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid , 1995, Diabetologia.

[124]  L. Packer,et al.  Dihydrolipoic acid--a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. , 1992, Biochemical pharmacology.

[125]  Min-Seon Kim,et al.  Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[126]  D. Leroith,et al.  A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.

[127]  D. Noonan,et al.  Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. , 2006, Carcinogenesis.

[128]  S. Vasdev,et al.  Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. , 2000, Journal of hypertension.

[129]  L. Packer,et al.  Assay of protein-bound lipoic acid in tissues by a new enzymatic method. , 1998, Analytical biochemistry.

[130]  M. Trujillo,et al.  Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. , 2002, Archives of biochemistry and biophysics.

[131]  A. Vollmar,et al.  Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. , 2007, Biochemistry.

[132]  T. Hagen,et al.  Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. , 2003, Biochemical Society transactions.

[133]  J. Cronan,et al.  Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system , 1991, Journal of bacteriology.

[134]  U. Çakatay,et al.  Postmitotic tissue selenium and manganese levels in alpha-lipoic acid-supplemented aged rats. , 2008, Chemico-Biological Interactions.

[135]  R. Hermann,et al.  Pharmacokinetics of Alpha‐Lipoic Acid in Subjects With Severe Kidney Damage and End‐Stage Renal Disease , 2005, Journal of clinical pharmacology.

[136]  L. Packer,et al.  Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. , 1991, Free radical research communications.

[137]  J. Krieglstein,et al.  Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. , 1996, Neuropharmacology.

[138]  C. Downes,et al.  Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. , 1995, Endocrinology.

[139]  R. Somwar,et al.  Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes , 2000, Diabetologia.

[140]  L. Packer,et al.  R-α-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes , 2002 .

[141]  D. Liebler,et al.  Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. , 2008, Chemical research in toxicology.

[142]  R. Moreau,et al.  Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. , 2002, Annals of the New York Academy of Sciences.

[143]  D. Bourdette,et al.  Lipoic acid stimulates cAMP production in T lymphocytes and NK cells. , 2007, Biochemical and biophysical research communications.

[144]  P. O'Brien,et al.  The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. , 2003, Diabetes care.

[145]  D. Cremer,et al.  Safety evaluation of alpha-lipoic acid (ALA). , 2006, Regulatory toxicology and pharmacology : RTP.

[146]  S. Vasdev,et al.  Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation. , 2003, Molecular and cellular biochemistry.

[147]  J. Blumberg,et al.  Differential Regulation of MAP Kinase Signaling by Pro‐ and Antioxidant Biothiols , 2000, Annals of the New York Academy of Sciences.

[148]  B. Halliwell,et al.  alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. , 1999, Free radical biology & medicine.

[149]  R. Wolfe,et al.  Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. , 1993, The American journal of physiology.

[150]  M. Widlansky,et al.  Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. , 2004, Current medicinal chemistry.

[151]  H. Huang,et al.  Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[152]  Min-Seon Kim,et al.  Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. , 2005, Biochemical and biophysical research communications.

[153]  H. Tritschler,et al.  Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. , 1998, International journal of clinical pharmacology and therapeutics.

[154]  D. Cremer,et al.  Long-term safety of α-lipoic acid (ALA) consumption: A 2-year study , 2006 .

[155]  A. Bast,et al.  Reduction of lipoic acid by lipoamide dehydrogenase. , 1996, Biochemical pharmacology.

[156]  U. Çakatay,et al.  Plasma protein oxidation in aging rats after alpha-lipoic acid administration , 2005, Biogerontology.

[157]  B. Ames,et al.  (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. , 2000, Antioxidants & redox signaling.

[158]  G. Sesti,et al.  Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.

[159]  S. Rhee,et al.  Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[160]  P. Low,et al.  Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[161]  M. Hanefeld,et al.  Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. , 1999, Diabetes care.

[162]  J. Blumberg,et al.  Homocysteine and α-Lipoic Acid Regulate p44/42 MAP Kinase Phosphorylation in NIH/3T3 Cells , 1999 .

[163]  J. M. May,et al.  Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells , 2002 .

[164]  M. Christopher,et al.  Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats. , 2004, Journal of animal physiology and animal nutrition.

[165]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[166]  T. Kronbach,et al.  New Metabolic Pathways of α-Lipoic Acid , 2001 .

[167]  L. Roccatagliata,et al.  α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.

[168]  P. Arivazhagan,et al.  Effect of DL-α-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats , 2002, Experimental Gerontology.

[169]  S. Jacob,et al.  The Antioxidant α-Lipoic Acid Enhances Insulin-Stimulated Glucose Metabolism in Insulin-Resistant Rat Skeletal Muscle , 1996, Diabetes.

[170]  L. Goodyear,et al.  Contraction signaling to glucose transport in skeletal muscle. , 2005, Journal of applied physiology.

[171]  R. Fernandes,et al.  Effects of α‐lipoic acid on endothelial function in aged diabetic and high‐fat fed rats , 2008 .

[172]  Min-Seon Kim,et al.  α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase , 2005 .

[173]  Hui Chen,et al.  Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. , 2002, Molecular endocrinology.

[174]  R. Moreau,et al.  Dietary supplementation with (R)-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex , 2005, Redox report : communications in free radical research.

[175]  S. Vasdev,et al.  Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats , 2005, Molecular and Cellular Biochemistry.